Ludovic Martinet

Publications

Poster de conférence (1)

Single-cell immune landscape associated with isatuximab, carfilzomib, lenalidomide, and dexamethasone induction efficacy in newly diagnosed myeloma Mael Penissat-Mahaut,Pierre-Paul Axisa,Hélène Daunes,Marine Cuisinier,Marie-Véronique Joubertet al. 67th ASH Annual Meeting, Dec 2025, Orlando, United States. Blood, 146 (Supplement 1), pp.3932-3932, 2025, ⟨10.1182/blood-2025-3932⟩ Poster de conférence hal-05555658v1

Article dans une revue (11)

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma Jan Eckmann,Tanja Fauti,Marlene Biehl,Aintzane Zabaleta,Laura Blancoet al. Blood, 2025, 145 (2), pp.202-219. ⟨10.1182/blood.2024025987⟩ Article dans une revue hal-05026338v1
NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma Eve Blanquart,Rüçhan Ekren,Bineta Rigaud,Marie-Véronique Joubert,Virginie Baylotet al. Blood, 2024, 144 (12), pp.1271-1283. ⟨10.1182/blood.2023023529⟩ Article dans une revue hal-05026334v1
Impact of the Multiple Sclerosis-Associated Genetic Variant CD226 Gly307Ser on Human CD8 T-Cell Functions Elena Morandi,Véronique Adoue,Isabelle Bernard,Ekaterina Friebel,Nicolas Nunezet al. Neurology Neuroimmunology & Neuroinflammation, 2024, 11 (6), pp.e200306. ⟨10.1212/NXI.0000000000200306⟩ Article dans une revue hal-04780777v1
RAS/RAF landscape in monoclonal plasma cell conditions Anais Schavgoulidze,Jill Corre,Mehmet Kemal Samur,Celine Mazzotti,Luka Pavageauet al. Blood, 2024, 144 (2), pp.201-205. ⟨10.1182/blood.2023022295⟩ Article dans une revue hal-05026345v1
TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation Andrea Pichler,Nadège Carrié,Marine Cuisinier,Samira Ghazali,Allison Voisinet al. Immunity, 2023, 56 (7), pp.1631-1648.e10. ⟨10.1016/j.immuni.2023.06.007⟩ Article dans une revue hal-04975485v1
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma Sahar Kassem,Béré Diallo,Nizar El-Murr,Nadège Carrié,Alexandre Tanget al. Blood, 2022, 139 (8), pp.1160-1176. ⟨10.1182/blood.2021012448⟩ Article dans une revue hal-05026353v1
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma Sahar Kassem,Béré Diallo,Nizar El-Murr,Nadège Carrié,Alexandre Tanget al. Blood, 2022, 139 (8), pp.1160-1176. ⟨10.1182/blood.2021012448⟩ Article dans une revue hal-03983352v1
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy Marianne Weulersse,Assia Asrir,Andrea C Pichler,Lea Lemaitre,Matthias Braunet al. Immunity, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩ Article dans une revue hal-03030829v1
Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma Léa Lemaitre,Laura Do Souto Ferreira,Marie-Véronique Joubert,Hervé Avet-Loiseau,Ludovic Martinetet al. International Journal of Molecular Sciences, 2020, 21 (11), pp.3854. ⟨10.3390/ijms21113854⟩ Article dans une revue hal-04693062v1
Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model Camille Guillerey,Kyohei Nakamura,Andrea Pichler,Deborah Barkauskas,Sophie Krumeichet al. JCI Insight, 2019, 4 (14), ⟨10.1172/jci.insight.125932⟩ Article dans une revue hal-05026492v1
TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma Camille Guillerey,Heidi Harjunpää,Nadège Carrié,Sahar Kassem,Tricia Teoet al. Blood, 2018, 132 (16), pp.1689-1694. ⟨10.1182/blood-2018-01-825265⟩ Article dans une revue hal-05026506v1